Skip to main content

Table 5 Unpaired T-test of the quantitative proteomic results for protein expression in the T2DM + LAC group in comparison with the control and T2DM groups

From: Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients

Protein

T2DM + LAC vs. control

T2DM + LAC vs. T2DM

Fold change

P value

Fold change

P value

ADIPO

−1.873

0.004

−1.629

0.199

CCD87

−1.664

 < 0.001

−1.440

 < 0.001

CXCL7

−2.700

0.018

−2.245

0.115

FBLN1

−1.506

0.016

−1.372

0.098

FHR1

1.613

0.010

1.510

0.025

FRPD2

−2.097

0.010

−1.751

0.035

HBB

−3.534

0.006

−2.188

0.019

HV145

−1.702

0.049

−1.392

0.138

IGFBP3

−1.765

0.044

−2.371

0.003

PZP

1.801

0.023

2.488

0.022

SRGN

1.624

0.038

1.573

0.131

ZN350

−1.679

0.028

−1.810

0.006

  1. LV316 was excluded because of be missing in most samples